BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/8/2022 12:06:55 PM | Browse: 449 | Download: 1757
 |
Received |
|
2021-03-19 02:02 |
|
Peer-Review Started |
|
2021-03-19 02:06 |
|
First Decision by Editorial Office Director |
|
2021-05-01 04:26 |
|
Return for Revision |
|
2021-05-08 00:41 |
|
Revised |
|
2021-05-10 23:32 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-05-25 08:58 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-05-25 11:32 |
|
Articles in Press |
|
2021-05-25 11:32 |
|
Edit the Manuscript by Language Editor |
|
2022-03-06 03:07 |
|
Typeset the Manuscript |
|
2022-03-24 06:56 |
|
Publish the Manuscript Online |
|
2022-04-08 12:06 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Min Yao, Jun-Ling Yang, De-Feng Wang, Li Wang, Ying Chen and Deng-Fu Yao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Nantong S&T Development Plan |
MS12020021 |
| National Natural Science Foundation of China |
81673241 |
| National Natural Science Foundation of China |
31872738 |
| Nantong S&T Development Plan |
MS12019016 |
|
| Corresponding Author |
Deng-Fu Yao, MD, PhD, Director, Director, Full Professor, Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, No. 20 West Temple Road, Nantong 226001, Jiangsu Province, China. yaodf@ahnmc.com |
| Key Words |
Hepatocellular carcinoma; Immunotherapy; Carcinoembryonic proteins; Specific biomarkers; Wnt/β-catenin pathway; Signal molecules |
| Core Tip |
Tissues in hepatocellular carcinoma (HCC) or hepatocyte malignant transformation can express and secrete a variety of molecules with specific biomarkers or oncogenic antigens into blood. These biomarkers not only contribute to the diagnosis and prognosis of HCC, they but also might become the molecular-targets for HCC treatment under developing or clinical trials. This article reviews the recent progress of some emerging biomarkers in basic researches or clinical trials for HCC immunotherapy. |
| Publish Date |
2022-04-08 12:06 |
| Citation |
Yao M, Yang JL, Wang DF, Wang L, Chen Y, Yao DF. Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma. World J Clin Cases 2022; 10(11): 3321-3333 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i11/3321.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i11.3321 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
